Here are 5 highlights of Infection Control Today® (TIC®’s) covers a wide range of the world of infection prevention and control. Everything from interviews with well-known thought leaders to insights that infection preventionists and other healthcare professionals can use in their work.
Hot Topics in IPC: Influenza, COVID-19, Mechanical Ventilation, and Drug-Resistant Pathogens
In this IPC Hot Topics, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses his concerns regarding COVID-19 and influenza for this winter, as well as mechanical ventilation and drug-resistant pathogens.
Intel on Infections: Chicopee, GP Pro, US FDA and Henry Schein
Stay ahead of the curve with company updates and product innovations. This week’s news comes from Chicopee, GP Pro, US FDA and Henry Schein.
Qnovia collaborates with UVA to develop new inhaled therapies for lung infections
Pharmaceutical company Qnovia is partnering with the University of Virginia (UVA) to create inhaled medications for lung infections, strengthening its development pipeline with assets for pneumonia and biodefense-related lung infections.
CDC advises on limited supply of Nirsevimab and options for protection against RSV
The Centers for Disease Control and Prevention advises providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody approved by the FDA to prevent respiratory syncytial virus (RSV), in infants most at risk for severe illness to VRS.
Encouraging results emerge from Phase 1/2 study of combined mRNA-based influenza and COVID-19 vaccines
With a safety profile consistent with that of Pfizer’s COVID-19 vaccine, this combination vaccine candidate will most likely advance to a Phase 3 trial in the coming months.
